Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Abalis Finance

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$7M
Portfolio companies 2
Rounds per year 0.20
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 1
Key employees 3
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Medical
  • Health Care
  • Therapeutic Devices
  • Therapeutics
Summary

Abalis Finance appeared to be the VC, which was created in 2006. The fund was located in Europe if to be more exact in Switzerland. The leading representative office of defined VC is situated in the Wollerau.

We also calculated 3 valuable employees in our database.

Among the various public portfolio startups of the fund, we may underline Activaero We can highlight the next thriving fund investment areas, such as Biotechnology, Medical. For fund there is no match between the location of its establishment and the land of its numerous investments - Germany. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Abalis Finance, startups are often financed by Vesalius Biocapital Partners, VI Partners AG, BioMedPartners. The meaningful sponsors for the fund in investment in the same round are Vesalius Biocapital Partners, VI Partners AG, BioMedPartners. In the next rounds fund is usually obtained by Vesalius Biocapital Partners, VI Partners AG, MedVenture Associates.

The increased amount of exits for fund were in 2014. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2011. Comparing to the other companies, this Abalis Finance performs on 4 percentage points more the average number of lead investments. The fund is generally included in less than 2 deals every year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Abalis Finance:
Typical Co-investors
Abalis Finance is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Abalis Finance:

Funds with similar focus

Funds from Switzerland
Funds with similar focus located in Switzerland:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Acidophil Baltimore, Maryland, United States
Aizawa Securities Japan, Tokyo
Cedar Street Group Larchmont, New York, United States
Dexin Investment China, Guangdong, Guangzhou
Fluxunit - Osram Ventures Bayern, Germany, München
Ford Smart Mobility California, Palo Alto, United States
HIT Robot Group Beijing, Beijing, China
International Development Bank Baghdad, Baghdad Governorate, Iraq
Marico India, Maharashtra, Mumbai
Miller Value Partners Baltimore, Maryland, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Activaero

Biotechnology
Health Care
Medical
Therapeutic Devices
$5M16 Feb 2011 Germany, Bavaria, Germany

Activaero

Biotechnology
Health Care
Medical
Therapeutic Devices
$15M20 Nov 2009 Germany, Bavaria

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Abalis Finance?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 7M
Rounds per year 0.20
Peak activity year 2011
Lead investments 1
Follow on index 0.33
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Activaero

Biotechnology
Health Care
Medical
Therapeutic Devices
$5M16 Feb 2011 Germany, Bavaria, Germany

Activaero

Biotechnology
Health Care
Medical
Therapeutic Devices
$15M20 Nov 2009 Germany, Bavaria
Crunchbase icon

Content report

The following text will be sent to our editors: